Tech Healthcare Sector

Agilent Technologies

Market Cap: US$41.1b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

BeOne Medicines

Market Cap: US$38.7b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

IQVIA Holdings

Market Cap: US$37.0b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

ResMed

Market Cap: US$35.6b

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.

GE HealthCare Technologies

Market Cap: US$34.1b

Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.

Natera

Market Cap: US$31.1b

A diagnostics company, provides molecular testing services worldwide.

Mettler-Toledo International

Market Cap: US$28.6b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Teva Pharmaceutical Industries

Market Cap: US$27.9b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Humana

Market Cap: US$26.9b

Provides medical and specialty insurance products in the United States.

STERIS

Market Cap: US$25.2b

Provides infection prevention products and services worldwide.

Biogen

Market Cap: US$24.7b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

BioNTech

Market Cap: US$23.3b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

DexCom

Market Cap: US$22.8b

A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

Waters

Market Cap: US$22.5b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Royalty Pharma

Market Cap: US$22.2b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Insulet

Market Cap: US$22.0b

Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

Sigma Healthcare

Market Cap: AU$33.9b

Operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia.

Labcorp Holdings

Market Cap: US$21.7b

Provides laboratory services.

Quest Diagnostics

Market Cap: US$20.9b

Provides diagnostic testing and services in the United States and internationally.

United Therapeutics

Market Cap: US$20.4b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Incyte

Market Cap: US$20.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Exact Sciences

Market Cap: US$19.1b

Provides cancer screening and diagnostic test products in the United States and internationally.

West Pharmaceutical Services

Market Cap: US$18.5b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Illumina

Market Cap: US$18.2b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Zimmer Biomet Holdings

Market Cap: US$17.7b

Operates as a medical technology company worldwide.

Centene

Market Cap: US$17.1b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.

Pro Medicus

Market Cap: AU$26.3b

A healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe.

Hologic

Market Cap: US$16.5b

Engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide.

Medpace Holdings

Market Cap: US$16.5b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Tenet Healthcare

Market Cap: US$16.4b

Operates as a diversified healthcare services company in the United States.

Cooper Companies

Market Cap: US$14.1b

Develops, manufactures, and markets contact lens wearers.

Roivant Sciences

Market Cap: US$14.1b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Universal Health Services

Market Cap: US$14.1b

Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities.

Smith & Nephew

Market Cap: UK£10.6b

Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

Neurocrine Biosciences

Market Cap: US$13.9b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Solventum

Market Cap: US$13.8b

A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.